Back to Startups

Aureka Biotechnologies

About Aureka Biotechnologies

Aureka Biotechnologies focuses on AI-driven antibody design, committed to democratizing the pharmaceutical industry to defeat disease.

Business Information
Target Customers
pharmaceutical companies biotech firms research institutions
Industry Categories
Bioscience & Disease AI, ML, Gen AI Healthcare Systems
Business Model
Revenue Model B2B
Pricing Strategy Custom pricing based on project scope
Sales Channels direct sales, partnerships with research institutions
Funding Timeline
Round Date Amount Investors
Series A Nov 10, 2025 $10.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
TMTPostGlobal
TMTPOST 钛媒体 @TMTPostGlobal
Nov 10, 2025

China's Aureka Biotechnologies Raises Tens of Millions Dollars in Series A to Advance AI-Driven Antibody Design 中国寻明生科获得数千万美元 A 轮融资,用于推进 AI 驱动的抗体设计https://t.co/bxMavwz2Je This round of financing will be used to advance the innovative pipeline under https://t.co/SgBy1SPZSJ